Peer Review History

Original SubmissionJune 13, 2020
Decision Letter - James Wolffsohn, Editor

PONE-D-20-18073

Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019

PLOS ONE

Dear Dr. Fekadu,

Thank you for submitting your manuscript to PLOS ONE. The reviewers are very complimentary of you manuscript, but there are a few minor clarifications to address

Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

James Wolffsohn, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0215528

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

3. Thank you for stating the following financial disclosure:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript"

At this time, please address the following queries:

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.
  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”
  3. If any authors received a salary from any of your funders, please state which authors and which funders.
  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

6. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: As the authors note, there are a number of peer-reviewed publications on the epidemiology of pterygium. Sun exposure is causal. The data in this paper further confirm previous findings of risk factors in a unique population-based study. A few suggestions/questions:

1. How was dust exposure defined?

2. How was sunglass use defined? Did participants have to wear them for a certain percent of tie while outdoors to be considered 'yes'?

3. Self-reported family history of pterygium is not likely to be accurate and not relevant to this paper, so I suggest deleting.

4. p<0.25 is an unusual significance level to use. How do the results change is a p<0.10 is used?

5. The independent variables in the multivariate analysis are likely highly corrected, this making interpretation challenging. How was that taken into account?

6. If the data are available, it would be interesting to assess a possible dose response relationship between sun exposure and size of pterygium.

Reviewer #2: I found this article well written and the topic interesting. I applaud the authors for the diligence and success in gathering data for this study. Though not material to the work reported here, I think the author would also be interest in exploring the work on peripheral light focusing by Kwok and Coroneo for future research, as it would provide illumination regarding the impact of wearing sunglasses on exposure related to pterygium

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Catherine McCarty Wallerstein

Reviewer #2: Yes: Cristina Schnider

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to reviewers

Manuscript title: Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019

Manuscript number: PONE-D-20-18073

Dear reviewers. Thank you for giving us the chance to revise and correct the manuscript accordingly. We are thankful so much and we appreciate you for careful and in-depth reading of this manuscript and for the thoughtful comments and constructive suggestions, which help us to improve the quality of this manuscript. Saying this we addressed all the concerns raised by you and incorporated our reflection in the revised manuscript. We tried to address all issues that are raised to be addressed.

Many thanks.

Reviewer reports:

Reviewer #1(Catherine McCarty Wallerstein): As the authors note, there are a number of peer-reviewed publications on the epidemiology of pterygium. Sun exposure is causal. The data in this paper further confirm previous findings of risk factors in a unique population-based study. A few suggestions/questions: 1. How was dust exposure defined?

Authors’ Response: Thank you! We accepted the comment and we included in the “operational definition” parts of the manuscript. Dust exposure: a person having at least a history of one episode of exposure to dusty environment that causes their eye to be irritated, itchy and red within the past 6 months(1).

Reviewer #1(Catherine McCarty Wallerstein): 2. How was sunglass use defined? Did participants have to wear them for a certain percent of tie while outdoors to be considered 'yes'?

Authors’ Response: Thank you! We accepted the comment and included in the operational definition part of the new revised manuscript. Sun glass use was defined as when participants used any type of glass(cosmetics, general and specially treated) for the purpose of protection from sun during their outdoor activities(2,3).

Reviewer #1(Catherine McCarty Wallerstein): 3. Self-reported family history of pterygium is not likely to be accurate and not relevant to this paper, so I suggest deleting.

Authors’ Response: Thank you! for the comment, the comment is accepted and we deleted it from the new edited manuscript.

Reviewer #1(Catherine McCarty Wallerstein): 4. p<0.25 is an unusual significance level to use. How do the results change is a p<0.10 is used?

Authors’ Response: Thank you! For the comment.

commonly used cutting point in bi-variable analysis to multivariable logistic regression is P< 0.20, but some statistician advice that when the variables that enter to multivariable analysis are fewer, it may possible to use the cutting point p<0. 25 and if we tried to use p< 0.10, variables will further be reduced and few not more than five will full fill the inclusion criteria which might reduce the precision of the study rather it is possible to enter all variables. in addition, the criteria developed in cutting the P-value in bivariable analysis is simply to reduce the number of variables that will inter to multivariable analysis. So, it is difficult to use p<.10, in our study since it will affect the whole outcome as well as statistical concept of the study.

Reviewer #1(Catherine McCarty Wallerstein): 5. The independent variables in the multivariate analysis are likely highly corrected, this making interpretation challenging. How was that taken into account.

Authors’ Response: Thank you! We write in such a way that, in order to be easily understand by the readers and the nature of the variables can not be compressed to a single word easily and we tried to write the manuscript so that the words can easily be understandable.

Reviewer #1(Catherine McCarty Wallerstein): 6. If the data are available, it would be interesting to assess a possible dose response relationship between sun exposure and size of pterygium.

Authors’ Response: Thank you! Since sun exposure was operationalized as “those who had exposure for five hours and above are considered as exposed and others as non-exposed” no separate dose of hour was included in the data. So, it is difficult to show the relationship between dose of sun exposure with size of pterygium.

Reviewer #2(Cristina Schnider): Thank you for your constructive comment and suggestion, we will try to conduct a future research in the topic/idea you suggested us and we hope we may face you again with that title.

Responses to accadamic editors

1. Response of authors: thank you, we tried to correct the manuscript to meet the Plos one’s criteria of manuscript formatting as much as possible.

2. Response of authors: thank you for your comment, we have already rephrased and correct the duplicated and overlapping texts in the new edited manuscript that were closer to the previous publication.

3. Response of authors: thank you,

A. As already mentioned previously, there were no a piece of financial and material support for this study, even the organization that employed us.

B. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

C. None of the authors received a salary from funders.

D. The authors received no specific funding for this work.

4. Thank you!

A. There is no ethical or legal restriction on sharing the data requested from us

B. Data are uploaded as “supporting information files” at the end of the new edited manuscript.

5. My ORCID iD is already updated from my PLOSE ONE account.

6. The ethics statement is already moved to method part in the new edited manuscript

References for comments reviewer # 1

1. De Smedt SK, Nkurikiye J, Fonteyne YS, Tuft SJ, Gilbert CE, Kestelyn P. Vernal keratoconjunctivitis in school children in rwanda: Clinical presentation, impact on school attendance, and access to medical care. Ophthalmology [Internet]. 2012;119(9):1766–72. Available from: http://dx.doi.org/10.1016/j.ophtha.2012.03.041

2. Backes C, Religi A, Moccozet L, Behar-Cohen F, Vuilleumier L, Bulliard JL, et al. Sun exposure to the eyes: predicted UV protection effectiveness of various sunglasses. J Expo Sci Environ Epidemiol [Internet]. 2019;29(6):753–64. Available from: http://dx.doi.org/10.1038/s41370-018-0087-0

3. Chorley AC, Evans BJW, Benwell MJ. Solar eye protection practices of civilian aircrew. Aerosp Med Hum Perform. 2015;86(11):953–61.

Attachments
Attachment
Submitted filename: Response to Reviwers.docx
Decision Letter - James Wolffsohn, Editor

Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019

PONE-D-20-18073R1

Dear Dr. Fekadu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

James Wolffsohn, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for carefully incorporating the reviewers comments to enhance your manuscript.

Reviewers' comments:

Formally Accepted
Acceptance Letter - James Wolffsohn, Editor

PONE-D-20-18073R1

Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019

Dear Dr. Fekadu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor James Wolffsohn

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .